Diasorin (OTC:DSRLF) Stock, Quote.Headers.trade-ideas

DiaSorin, headquartered in Italy, is a global provider of in vitro diagnostics, or IVD, which refers to testing done on samples taken from the human body, such as blood and tissue. DiaSorin produces and markets testing reagent kits for immunodiagnostics (about 65% of total sales) and molecular diagnostics (about 20%) and has a total installed base of about 9,000 diagnostic systems. Instruments and other revenue contribute about 15% of total sales. DiaSorin's largest market in 2023 was North America, which accounted for 48% of non-covid revenue, followed by Europe (35%) and the Rest of the World (18%).

Biotech

News

Health Care

Small Cap

General

DSRLF

LMNX

DiaSorin Acquires COVID-19 Test Maker Luminex For $37 Per Share

Diasorin SpA

Diasorin

Comments

Diasorin

Diasorin (OTC:DSRLF) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga